Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
12,618.00
13.1 (0.1%)
BSENSE

Apr 01

BSE+NSE Vol: 30.12 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "12,618.00",
    "chg": 13.1,
    "chgp": "0.1%",
    "dir": 1,
    "prev_price": "12,604.90",
    "mcapval": "16,299.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "Apr 01",
    "curr_time": "",
    "bse_nse_vol": "30.12 k",
    "exc_status": "Active",
    "traded_date": "Apr 01, 2026",
    "traded_date_str": "2026 04 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3922665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3922665.png",
        "date": "2026-03-29 10:10:37",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3898294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3898294.png",
        "date": "2026-03-18 10:11:11",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-strong-sell-3877795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NeulandLaborato_mojoScore_3877795.png",
        "date": "2026-03-07 10:10:38",
        "description": "Neuland Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Falls 2.99%: 3 Key Technical and Fundamental Factors Driving the Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-falls-299-3-key-technical-and-fundamental-factors-driving-the-decline-3863179",
        "imagepath": "",
        "date": "2026-03-01 11:01:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Downgrade to Sell rating announced amid financial and technical weakness</p>\n                    <p><strong>18 Feb:</strong> Technical momentum shifts to sideways with mixed indicator signals</p>\n                    <p><strong>20 Feb:</strong> Mildly bearish technical shift amid market volatility and price decline</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13,242.00</div></div>\n                    <div class=\"stat-item\"><div cla..."
      },
      {
        "title": "Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-121-4-key-factors-driving-the-weeks-mixed-momentum-3862734",
        "imagepath": "",
        "date": "2026-02-28 17:08:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Intraday high surge of 7.89% to Rs.13,652.75</p>\n                    <p><strong>23 Feb:</strong> Formation of Death Cross signalling bearish trend</p>\n                    <p><strong>24 Feb:</strong> Downgrade to Strong Sell amid deteriorating fundamentals</p>\n                    <p><strong>24 Feb:</strong> Shift from mildly bearish to bearish technical trend</p>\n                    <p><strong>27 Feb:</strong> Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12,654.10</div></div>\n  ..."
      },
      {
        "title": "Neuland Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3852270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_mojoScore_3852270.png",
        "date": "2026-02-24 08:08:08",
        "description": "Neuland Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 23 February 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical company’s Mojo Score has dropped to 28.0, signalling heightened caution for investors amid a challenging financial and market environment."
      },
      {
        "title": "Neuland Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-3851957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3851957.png",
        "date": "2026-02-24 08:01:09",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a strong day change of 7.89%, the stock’s technical parameters, including MACD, RSI, and moving averages, suggest caution for investors amid mixed signals and deteriorating momentum."
      },
      {
        "title": "Neuland Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-3851786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_dealthcross_3851786.png",
        "date": "2026-02-23 18:00:21",
        "description": "Neuland Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum amid challenging market conditions."
      },
      {
        "title": "Neuland Laboratories Ltd Hits Intraday High with 7.5% Surge on 23 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-75-surge-on-23-feb-2026-3851743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_priceRelatedfactors_3851743.png",
        "date": "2026-02-23 15:01:28",
        "description": "Neuland Laboratories Ltd recorded a robust intraday performance on 23 Feb 2026, surging to a day’s high of Rs 13,630, marking a 7.71% increase. This sharp uptick outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting a notable rebound after three consecutive days of decline."
      }
    ],
    "total": 748,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
      "datetime": "27-Mar-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2026 for Davuluri Rao",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
      "datetime": "19-Mar-2026",
      "details": "Issue of Letter of Confirmation in lieu of Share Certificate(s) lost / misplaced",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Neuland Laboratories Falls 2.99%: 3 Key Technical and Fundamental Factors Driving the Decline

2026-03-01 11:01:02

Key Events This Week

16 Feb: Downgrade to Sell rating announced amid financial and technical weakness

18 Feb: Technical momentum shifts to sideways with mixed indicator signals

20 Feb: Mildly bearish technical shift amid market volatility and price decline

20 Feb: Week closes at Rs.12,654.10 (-2.99%) vs Sensex +0.39%

Neuland Laboratories Gains 1.21%: 4 Key Factors Driving the Week’s Mixed Momentum

2026-02-28 17:08:42

Key Events This Week

23 Feb: Intraday high surge of 7.89% to Rs.13,652.75

23 Feb: Formation of Death Cross signalling bearish trend

24 Feb: Downgrade to Strong Sell amid deteriorating fundamentals

24 Feb: Shift from mildly bearish to bearish technical trend

27 Feb: Week closes at Rs.12,806.85 (+1.21%) outperforming Sensex

stock-recommendationAnnouncement

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

27-Mar-2026 | Source : BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2026 for Davuluri Rao

Closure of Trading Window

23-Mar-2026 | Source : BSE

Closure of Trading Window

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

19-Mar-2026 | Source : BSE

Issue of Letter of Confirmation in lieu of Share Certificate(s) lost / misplaced

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Neuland Laboratories Ltd has declared 120% dividend, ex-date: 18 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14